Pomerantz LLP Appointed Lead Counsel in Nabriva Therapeutics plc Securities Litigation
On July 22, 2019, Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit against Nabriva Therapeutics.
On July 22, 2019, Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit against Nabriva Therapeutics.